Efficacy of thalidomide in alleviating adverse reactions induced by apatinib in bone and soft-tissue carcinoma: a retrospective cohort study

QING Yan-wei; HU Hai-yan; LIU Yuan; ZHANG Lin; YANG Cheng; WANG Qiong

doi:10.3969/j.issn.2095-252X.2022.01.005

Home>Articles>Efficacy of thalidomide in alleviating adverse reactions induced by apatinib in bone and soft-tissue carcinoma: a retrospective cohort study

DOI: 10.3969/j.issn.2095-252X.2022.01.005

Efficacy of thalidomide in alleviating adverse reactions induced by apatinib in bone and soft-tissue carcinoma: a retrospective cohort study

QING Yan-wei

HU Hai-yan

LIU Yuan

ZHANG Lin

YANG Cheng

WANG Qiong

Machine-generated Keywords：

Publication Date：2022-01-19

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 27-31 )

Chinese Journal of Bone and Joint

ISTIC

ISSN：2095-252X

Year, Vol.(Issue)：2022,11(1)